FDA inspection
Fisher Pharmaceuticals Ltd.: FDA inspection ending Jul 28, 2022
FDA inspection 1177288 · Official Action Indicated (OAI) · Tiberias Elite
Key facts
| Inspection ID | 1177288 |
|---|---|
| Firm | Fisher Pharmaceuticals Ltd. |
| FEI number | 3002750286 |
| Address | Kidmat Galilee Industrial Zone |
| City | Tiberias Elite |
| Country | Israel |
| Fiscal year | 2022 |
| Inspection end date | Jul 28, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data